Suppr超能文献

糖尿病血瘀证及血府逐瘀汤对大鼠视网膜Müller细胞中ROS-ERK1/2信号通路的影响

Effect of diabetes blood-stasis syndrome and Xuefu Zhuyu decoction on ROS-ERK1/2 signaling pathway in rat retina Müller cells.

作者信息

Ye Xiaofeng, Ren Hui, Jiang Tingting, Zhang Ting, Li Gang

机构信息

Eye Institute, EENT Hospital, Fudan University, No. 83 Fenyang Road, Shanghai, 200031, China.

Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University, Shanghai, 200031, China.

出版信息

Cytotechnology. 2020 Apr;72(2):303-314. doi: 10.1007/s10616-020-00379-7. Epub 2020 Feb 28.

Abstract

This research aimed to investigate whether diabetic blood-stasis syndrome had a relationship with ROS-ERK1/2 signaling pathway in rat retina Müller cells and explore the effects of traditional Chinese drugs designed for promoting blood circulation to remove blood stasis on diabetic retinopathy (DR) treatment. Immunofluorescence was applied to determine purity of Müller cells. The diabetes was induced in rats by streptozotocin (STZ). Müller cells were stimulated by blood serum obtained from rats with blood-stasis syndrome and then treated by Xuefu Zhuyu decoction. Kits for reactive oxygen species (ROS), superoxide dismutase (SOD) and glutathione (GSH) were used for corresponding detection. Western blot analysis was used to determine the phosphorylation of ERK1/2. The results indicated that stimulation of Müller cells by blood serum of rats with diabetic blood-stasis syndrome increased the expression of ROS, inhibited SOD and GSH, and activated ERK1/2 signaling pathway. Treatment of Xuefu Zhuyu decoction could weaken this phenomenon. What's more, similar effects of ERK1/2 inhibitor U0126 with Xuefu Zhuyu decoction proved the involvement of ERK1/2 signaling pathway. Therefore, our results suggested that traditional Chinese drugs for promoting blood circulation to remove blood stasis would be an effective therapy to treat DR.

摘要

本研究旨在探讨糖尿病血瘀证与大鼠视网膜Müller细胞中ROS-ERK1/2信号通路是否存在关联,并探究活血化瘀类中药对糖尿病视网膜病变(DR)治疗的作用。应用免疫荧光法测定Müller细胞的纯度。采用链脲佐菌素(STZ)诱导大鼠患糖尿病。用血瘀证大鼠血清刺激Müller细胞,然后用血府逐瘀汤进行治疗。使用活性氧(ROS)、超氧化物歧化酶(SOD)和谷胱甘肽(GSH)试剂盒进行相应检测。采用蛋白质免疫印迹分析来测定ERK1/2的磷酸化水平。结果表明,糖尿病血瘀证大鼠血清刺激Müller细胞可增加ROS的表达,抑制SOD和GSH,并激活ERK1/2信号通路。血府逐瘀汤治疗可减弱这一现象。此外,ERK1/2抑制剂U0126与血府逐瘀汤具有相似作用,证实ERK1/2信号通路参与其中。因此,我们的结果提示,活血化瘀类中药将是治疗DR的有效疗法。

相似文献

本文引用的文献

5
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.雷珠单抗治疗糖尿病性视网膜病变的综述
Ophthalmol Ther. 2017 Jun;6(1):33-47. doi: 10.1007/s40123-017-0083-9. Epub 2017 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验